β-amyloïde (25-35), met HFIP behandeld

β-Amyloid (25-35) (Amyloid beta-peptide (25-35) ), HFIP-treated is a β-Amyloid (25-35) treated with HFIP. β-Amyloid (25-35) (Amyloid beta-peptide (25-35) ) is the fragment Aβ (25-35) of the Alzheimer's amyloid β-peptide, has shown neurotoxic activities in cultured cells[1].

131602-53-4

Amyloid beta-peptide (25-35), HFIP-treated; Aβ25-35, HFIP-treated; β-Amyloid peptide (25-35), HFIP-treated

12352209

Amyloid-β

Neuronal Signaling

Neuroscience-Neurodegeneration

Neurological Disease

99.71

CSCC[C@@H](C(O)=O)NC([C@H](CC(C)C)NC(CNC([C@H]([C@@H](C)CC)NC([C@H]([C@@H](C)CC)NC([C@H](C)NC(CNC([C@H](CCCCN)NC([C@H](CC(N)=O)NC([C@H](CO)NC(CN)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O

C45H81N13O14S

1060.27

[1]D'Ursi AM, et al. Solution structure of amyloid beta-peptide (25-35) in different media. J Med Chem. 2004 Aug 12;47 (17) :4231-8.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P0128A/β-Amyloid-25-35-HFIP-treated-SDS-MedChemExpress.pdf

Peptides

No Development Reported